SPRY1 and prostate intraepithelial neoplasia: As all Spry1+/− mice assessed had PIN pathology, it is possible that a dose effect is seen such that Spry2 is increased in Spry1 null mice to compensate where Spry2 is the most important of the sprouty family negative regulators of FGF signalling.